Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

68 insider filings · Latest: Aug 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 21, 2025Apr 21 8:37 PMMelissa Baird
Proposed Sale
33,333$25.84$861.3K

View →

Apr 16, 2025Apr 16 2:44 PMDudum Andrew
Proposed Sale
83,994$28.15$2.4M

View →

Apr 14, 2025Apr 14 1:52 PMBoughton Soleil
Proposed Sale
3,236$28.72$92.9K

View →

Apr 9, 2025Apr 9 8:42 PMMelissa Baird
Proposed Sale
33,337$29.49$983.1K

View →

Apr 3, 2025Apr 3 2:29 PMBecklund Irene
Proposed Sale
2,203$28.78$63.4K

View →

Mar 31, 2025Mar 31 1:54 PMBoughton Soleil
Proposed Sale
3,236$27.77$89.9K

View →

Mar 26, 2025Mar 26 8:09 PMMelissa Baird
Proposed Sale
67,687$33.36$2.3M

View →

Mar 21, 2025Mar 21 9:00 PMOluyemi Okupe
Proposed Sale
69,442$34.75$2.4M

View →

Mar 18, 2025Mar 18 4:24 PMDudum Andrew
Proposed Sale
78,760$33.85$2.7M

View →

Mar 18, 2025Mar 18 2:56 PMBoughton Soleil
Proposed Sale
3,236$34.31$111.0K

View →

Mar 18, 2025Mar 18 2:52 PMCarroll Patrick Harrison
Proposed Sale
23,287$34.31$799.0K

View →

Mar 18, 2025Mar 18 2:24 PMBecklund Irene
Proposed Sale
8,277$34.31$284.0K

View →

Mar 17, 2025Mar 17 7:26 PMDudum Andrew
Proposed Sale
175,661$33.89$6.0M

View →

Mar 11, 2025Mar 11 2:03 PMBecklund Irene
Proposed Sale
2,203$34.77$76.6K

View →

Mar 5, 2025Mar 5 4:40 PMPendarvis Christiane
Proposed Sale
12,500$40.00$500.0K

View →

Mar 3, 2025Mar 3 4:59 PMBecklund Irene
Proposed Sale
2,913$45.14$131.5K

View →

Mar 3, 2025Mar 3 4:45 PMBoughton Soleil
Proposed Sale
4,151$45.14$187.4K

View →

Feb 24, 2025Feb 24 3:46 PMChi Michael
Proposed Sale
17,303$48.14$833.0K

View →

Feb 19, 2025Feb 19 3:16 PMChi Michael
Proposed Sale
7,500$59.26$444.4K

View →

Feb 18, 2025Feb 18 4:22 PMBoughton Soleil
Proposed Sale
4,152$60.69$252.0K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 6, 2026Apr 7 9:14 PMOluyemi OkupeChief Financial Officer
Option Exercise
3,975$5.01135,587(D)

View →

Mar 20, 2026Mar 24 10:09 PMOluyemi OkupeChief Financial Officer
Option Exercise
4,489$5.01139,562(D)

View →

Mar 13, 2026Mar 17 8:29 PMMichael ChiChief Operating Officer
Option Exercise
72,108127,191(D)

View →

Mar 13, 2026Mar 17 8:29 PMChristiane PendarvisDirector
Option Exercise
15,2110(D)

View →

Mar 13, 2026Mar 17 8:29 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Option Exercise
16,52242,397(D)

View →

Mar 13, 2026Mar 17 8:29 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
32,919493,792(D)

View →

Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,98716,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,42174,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,07662,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 3 of 3